Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$571,825
+$36,535 QoQ
Shares Held
4,450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#2,579
of 3,769 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Millennium Capital Advisors, LLC holds $10,220,889 across 6 Drug Manufacturers - General names. MRK ranks #5 (5.6% of the industry book) .
All Filings in MRK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571,825 | 4,450 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $535,290 | 4,450 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $457,881 | 4,350 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $348,309 | 4,150 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $328,514 | 4,150 | Shares | Sole | 2026-02-18 | |
| 2025-03-31 | $418,461 | 4,662 | Shares | Sole | 2026-02-18 | |
| 2024-12-31 | $503,567 | 5,062 | Shares | Sole | 2026-02-18 | |
| 2024-09-30 | $610,952 | 5,380 | Shares | Sole | 2026-02-18 | |
| 2024-06-30 | $677,805 | 5,475 | Shares | Sole | 2026-02-18 | |
| 2024-03-31 | $719,127 | 5,450 | Shares | Sole | 2026-02-18 | |
| 2023-12-31 | $594,159 | 5,450 | Shares | Sole | 2026-02-18 | |
| 2023-09-30 | $674,322 | 6,550 | Shares | Sole | 2026-02-18 | |
| 2023-06-30 | $786,036 | 6,812 | Shares | Sole | 2026-02-18 | |
| 2023-03-31 | $708,982 | 6,664 | Shares | Sole | 2026-02-18 | |
| 2022-12-31 | $721,618 | 6,504 | Shares | Sole | 2026-02-18 | |
| 2022-09-30 | $518,700 | 6,023 | Shares | Sole | 2026-02-18 | |
| 2022-06-30 | $516,295 | 5,663 | Shares | Sole | 2026-02-18 | |
| 2022-03-31 | $399,419 | 4,868 | Shares | Sole | 2026-02-18 | |
| 2021-12-31 | $319,435 | 4,168 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||